The Interactive Medical Intelligence Zone is a needs assessment-driven continuing medical education (CME) activity that utilizes national and international experts to provide evidence-based, guideline-consistent, and practice behavior-changing information focused on critical and challenging topics in clinical medicine.
To ensure that the educational content of iQ&A programs will address practice gaps in clinical medicine, improve patient outcomes, and positively guide clinical practice strategies, international experts, usually in a roundtable format, will respond to questions submitted and/or generated by practitioners at CME mega-symposia, national congress, association meetings, or as part of on-line, enduring CME programs.
Questions reflecting the clinical needs of practitioners are then answered, analyzed, and discussed by international experts, who provide evidence-based and clinically relevant guidance that is independently of commercial sources or the program sponsor..

The iQ&A platform stresses:

Program Medium
Internet-based program

Method of Physician Participation Utilized in Learning Process

There are no fees for participating and receiving CME credit for this activity. During the period March 15, 2017 through March 15, 2019, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all 115 segments, totaling 3 hours, to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out CME certificate.

Estimated Time to Complete Educational Activity

3.0 hours. Physicians must study the enduring activity, and are expected to view every segment to successfully complete the activity and earn CME credit.

Course Overview

In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to improve the management of Type 2 diabetes.

Release Date

March 15, 2017

Expiration Date

March 15, 2019

Intended Audience

This complimentary CME educational activity is designed for all healthcare providers (HCPs) involved in developing, delivering, consulting, and monitoring care for patients with or at risk for Type 2 diabetes..


Participation in this iQ&A interactive Medical Intelligence Zone for Rheumatoid Arthritis is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support

This activity is supported by an independent medical education grant from Novo Nordisk

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Massachusetts Medical School Office of Continuing Medical Education (UMMS-OCME) and CMEducation Resources, LLC. The UMMS-OCME is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Massachusetts Medical School designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Policy on Faculty & Provider Disclosure

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials. 

Program Faculty and Disclosure

Program Faculty and Disclosure
Vivian Fonseca, MD – Program Chair

Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
Past President, Science and Medicine
American Diabetes Association

Research Support (to Tulane): Novo Nordisk, Asahi, Eli Lilly, Abbott, Endo Barrier, Gilead Sciences
Honoraria for Consulting and Lectures: Takeda, Novo Nordisk, Sanofi-Aventis, Eli Lilly, Pamlabs, AstraZeneca, Abbott, Amgen, Boehringer Ingelheim, Janssen

Steve Bain, MD
Professor of Medicine (Diabetes)
College of Medicine
Swansea University
Swansea, UK

Nothing to disclose

Jaime Davidson, MD, FACP, MACE
Clinical Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism
University of Texas Southwestern Medical School
Dallas, TX

Advisor or Consultant: Amgen Inc.; Aspire Bariatrics; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; GlaxoSmithKline; Janssen Pharmaceuticals, Inc.; LifeScan, Inc.; Lilly; Merck & Co., Inc.; Novo Nordisk; REMD Bio; Sanofi
Speaker: AstraZeneca Pharmaceuticals LP; Janssen Pharmaceuticals, Inc.; Novo Nordisk; Takeda Pharmaceuticals North America, Inc.

Ralph DeFronzo, MD
Professor of Medicine
The University of Texas Health Science Center at San Antonio
San Antonio, TX

Consulting: AstraZeneca, Janssen, Intarcia, Novo Nordisk
Fees for Non-CME/CE Services: AstraZeneca, Novo Nordisk
Ownership Interest (Stocks, stock options, etc): AstraZeneca, Janssen

Stefano Del Prato, MD PhD
Professor of Endocrinology and Metabolism
School of Medicine, University of Pisa
Chief of the Section of Diabetes
University of Pisa, Italy
Clinical Associate Professor of Medicine
University of Texas, San Antonio Health Science Center
San Antonio, TX

Consulting: Novo Nordisk, Boehringer-Ingelheim, Lilly, Pfizer, Sanofi
Speaker’s Bureau: Novo Nordisk, Merck, AstraZeneca, Janssen

Juan P. Frias, MD, FACE
Clinical Assistant Professor of Medicine
University of California
San Diego, California
Chief Medical Officer
National Research Institute
Los Angeles, California

Consulting Fees: Johnson and Johnson, Astra Zeneca, Sanofi
Contracted Research: Astra Zeneca, Boehringer Ingelheim, BMS, Lilly, Novo Nordisk, Merck, Pfizer, Sanofi

Luc Van Gaal, MD
Professor of Medicine
Department of Endocrinology, Diabetology and Metabolism
Antwerp University Hospital
Antwerp, Belgium

Nothing to disclose

Robert Henry, MD
Chief, Center for Metabolic Research
Chief, Section of Endocrinology, Metabolism & Diabetes
Veterans Affairs Healthcare System
Professor of Medicine‚ Department of Medicine
Division of Endocrinology and Metabolism
University of California‚ San Diego

Advisor or consultant: Alere; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc; Elcelyx Therapeutics, Inc; Ionis Pharmaceuticals; Intarcia Therapeutics, Inc.; Janssen Pharmaceuticals; Johnson & Johnson Pharmaceutical Research & Development, LLC; Novo Nordisk; Sanofi
Grants/Research Support: AstaReal; Boehringer Ingelheim Pharmaceuticals, Inc; Hitachi; Lexicon Pharmaceuticals, Inc.; Lilly; Novo Nordisk; REMD Biotherapeutics; ViaCyte, Inc

Serge A. Jabbour, MD, FACP, FACE
Professor of Medicine
Thomas Jefferson University
Division of Endocrinology, Diabetes and Metabolic Diseases
Department of Medicine
Jefferson Medical College
Philadelphia, Pennsylvania

Consulting: AstraZeneca, Johnson & Johnson, Lilly and Boehringer-Ingelheim
Fees for Non-CME/CE Services: AstraZeneca, Johnson & Johnson, Lilly

Lawrence A. Leiter, MD, FRCP(C), FACP
Head, Division of Endocrinology and Metabolism
Director, Lipid Clinic
Associate Director, Clinical Nutrition and Risk Factor Modification Centre
St. Michael’s Hospital
Professor, Medicine and Nutritional Sciences
University of Toronto
Toronto, Ontario

Consulting: Astra Zeneca, BI, Eli Lilly, Janssen, Merck, Novo Nordisk, Sanofi, Servier
Speakers Bureau: Astra Zeneca, BI, Eli Lilly, Janssen, Merck, Novo Nordisk, Sanofi
Contracted Research: Astra Zeneca, BI, Eli Lilly, GSK, Janssen, Merck, Novo Nordisk, Pfizer, Sanofi, Servier

Johannes F.E. Mann, MD
Professor of Medicine
University of Erlangen-Nürnberg
Director, Dept. of Nephrology, Hypertension & Rheumatology
Munich General Hospitals
Munich, Germany

Nothing to disclose

Chantal Mathieu, MD, PhD
Professor of Medicine
Program Director of Biomedical Sciences
Katholieke Universiteit
Chair of Endocrinology
University Hospital Gasthuisberg
Leuven, Belgium

Advisory Board, Research Support, and Speaker: Novo Nordisk, Medtronic, Roche, Sanofi, Boehringer Ingelheim, AstraZeneca

John Petrie, MD, PhD
Professor of Diabetic Medicine
University of Glasgow
Honorary Consultant Physician and Diabetologist
Glasgow Royal Infirmary and Stobhill Hospital
Glasgow, Scotland

Nothing to disclose

Richard Pratley, MD
Senior Investigator
Translational Research Institute for Metabolism and Diabetes
Medical Director, Florida Hospital Diabetes Institute (FHDI)
Professor, Sanford-Burnham Medical Research Institute at Lake Nona
Orlando, Florida

Contracted Research: Novo Nordisk, Merck, Sanofi, Lexicon, Lilly

Itamar Raz, MD
Professor of Internal Medicine
Head of the Diabetes Unit
Hadassah University Hospital
Jerusalem, Israel

Consulting: AstraZeneca, Eli Lilly

Josep Vidal, MD, PhD
Obesity Unit, Endocrinology and Diabetes Unit
University Hospital Clinic
Barcelona, Spain

Nothing to disclose

Program Managers and Web Editor Disclosure

Program Manager Gideon Bosker, MD has nothing to disclose.

Program Reviewer Denise Leary has nothing to disclose.

Educational Objectives

Upon completion of this activity, participants will be able to: Compare and contrast the various technologies used to detect actionable mutational targets in cancer

Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate.

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:


Copyright © 2017 by CMEducation Resources, LLC All rights reserved. 

Reproduction, distribution, or translation without express written permission is strictly prohibited. 

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity. 

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations. 

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman. 

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © CMEducation Resources, LLC

Click here to indicate that you have read this CME information statement and wish to participate in this CME activity.

iQ&A Interactive Medical Intelligence Zone for DIABETES